** Shares of medical device maker Dexcom DXCM.O rise 3.9% to $72.98 premarket
** Late on Thursday, co posted Q1 sales of $1.04 bln, above analysts' est of $1.02 bln - LSEG
** Co reiterated its annual sales forecast of $4.60 bln; analysts were expecting 2025 sales of $4.61 bln - LSEG
** J.P.Morgan analyst Robbie Marcus said the co has taken a "conservative approach" and expects to see "outperformance over the balance of the year"
** Co reports Q1 adj profit of 32 cents/share, compared with est of 33 cents/share - LSEG
** As of last close, stock down 9.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。